Navigation Links
Grant for 'rotten eggs' anti-inflammatory research
Date:8/20/2010

A research project at the Peninsula Medical School in Exeter, which will study the effect of hydrogen sulfide (H2S - the 'rotten eggs' gas) as an effective anti-inflammatory agent, has won a research grant of 140,000 over three years from the Wellcome Trust.

H2S occurs naturally in the body and, when in balance with other chemical compounds that occur naturally in humans, promotes good health.

Last year the research team investigated the role of H2S in toxic shock, which causes a fatal loss of blood pressure and extensive tissue inflammation. They discovered that when H2S is delivered in a slow and sustained manner it works as an effective anti-inflammatory. Cell signaling molecules that drive inflammation were reduced while levels of the body's own anti-inflammatory molecules were increased.

The Wellcome Trust grant will fund further studies to investigate how H2S and its controlled delivery in the body could pave the way for the development of new approaches to the treatment of inflammatory disorders.

The funding will allow the research team to expand their work into the clinical setting. They strongly believe that this new and innovative area of research could hold the key to a range of applications for human health. They have already shown that H2S releasing molecules synthesised by them are beneficial in models of high blood pressure and they are part of a cohort of researchers worldwide who are only just starting to unravel the role of H2S has in the body in health and disease.

Dr. Matt Whiteman from the Peninsula Medical School, Exeter commented: "We are very excited to have won Wellcome Trust support which will allow us to further develop our work. We have known for a few years that H2S levels in tissue and blood are substantially elevated during inflammation. It was assumed that this was a bad thing. However, our research is suggesting that levels of H2S could be elevated as part of the body's way to limit and resolve inflammation."

He added: "Although traditional anti-inflammatory drugs are very effective and safe, they can sometimes damage the stomach lining leading to further complications. Generating H2S in a controlled and sustained manner offers the potential for the development of a new group of anti-inflammatory drugs or lead to the modification of existing drugs so they also release H2S and hopefully come with less gastrointestinal side-effects. Our next round of research could revolutionise the way in which anti-inflammatory interventions are developed and administered."

Earlier research into the role of H2S in the body had been funded locally by the Northcott Devon Medical Foundation.


'/>"/>

Contact: Andrew Gould
andrew.gould@pms.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Related medicine news :

1. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
2. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
3. Autism Science Foundation Offers IMFAR Grants to Autism Stakeholders
4. Perrigo Granted Summary Judgment of Non-Infringement in Mucinex(R) Case
5. US21, Inc. is Granted a Wholesale Distributor Permit from the Commonwealth of Virginia Board of Pharmacy
6. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
7. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
8. Special Olympics Georgia Receives Grant from The Home Depot Foundation
9. NIH grant will create behavioral health registry for pediatric inflammatory bowel disease
10. San Diego Unified School District Awarded Silent Hero Grant From got breakfast?(R) Foundation
11. Congressional Staff Briefing, Wed., Feb. 24 on Mental Health, Medicaid & Block Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: